Event Type
Disclosure
Mandatory
Variant
8-K
shall not be incorporated by reference in any of Aurinia's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or aft
Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description 99.1 Press release dated February 26, 2026, Aurinia Pharmaceuticals Reports Financial Re